Median salary
$66,279
per year · annualized USD
Typical range
$40.3k – $99.5k
25th–75th percentile
Disclosing pay
11.2%
317 of 2,829 roles
Live roles
2,829
open right now
Senior Medical Director, Oncology Clinical Development - GU
Executive Medical Director, Clinical Development Lead - Oncology GU
Medical Director, Oncology Clinical Development - GU
Sr. Director, Procurement Strategy, Digital and Process, Orthopedics
Sr. Director, Global Benefits COE – Orthopedics
Director, Health Systems Value Strategy
Director R&D Project Management
Director, Process & Operations Management, Medical and Scientific Affairs (MSA)
| Company | Median | Roles |
|---|---|---|
Johnson & Johnson
|
$139,550 | 43 |
Bristol Myers Squibb
|
$68,226 | 33 |
IQVIA
|
$58,615 | 31 |
Stryker
|
$49,746 | 18 |
Workday
|
$53,357 | 15 |
| BI Biogen | $35,073 | 13 |
GSK
|
$129,822 | 12 |
Sanofi
|
$80,431 | 9 |
| Role | Median | Roles |
|---|---|---|
| Software Engineer | $85,120 | 16 |
| Project Manager | $74,493 | 4 |
| Product Manager | $66,472 | 7 |
| Marketing Manager | $64,196 | 7 |
| Customer Success | $50,090 | 3 |
| Sales | $32,461 | 6 |
See every role in Warsaw
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for roles in Warsaw is $66,279 per year. Most pay falls between $40,308 (25th percentile) and $99,487 (75th percentile), with the broader 10th–90th percentile band running from $28,982 to $140,255.
These figures are computed live from 2,829 active roles in Warsaw on JobsRadar, of which 317 (11.2%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid roles in Warsaw include GSK and Johnson & Johnson.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.